Studies have shown that the expression of RIPK2 is significantly upregulated in the intestinal mucosa of IBD patients, promoting the release of inflammatory factors and thereby exacerbating local inflammatory responses. The gene discussed is RIPK2; the disease is inflammatory bowel disease.